Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification. Liu Z, Liu J, Liu R, Xue M, et al. BMC Cancer 2021;21:367.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Z, Liu J, Liu R, Xue M, et al. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification. BMC Cancer 2021;21:367.
PMID: 33827486